Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology

[1]  L. Bailey,et al.  In situ pericardial extracardiac lateral tunnel Fontan operation: fifteen-year experience. , 2010, The Journal of thoracic and cardiovascular surgery.

[2]  E. Neufeld,et al.  Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. , 2009, Journal of Thoracic and Cardiovascular Surgery.

[3]  F. Kirkham,et al.  Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[4]  N. B. Lerner,et al.  Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. , 2007, The Annals of thoracic surgery.

[5]  E. Malec,et al.  Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  W. van Oeveren,et al.  Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity , 2006, Critical care.

[7]  D. Byrne,et al.  Inhaled nitric oxide use in bidirectional Glenn anastomosis for elevated Glenn pressures. , 2006, The Annals of thoracic surgery.

[8]  P. Monagle Thrombosis in children with BT shunts, Glenns and Fontans , 2005 .

[9]  Y. Cheung,et al.  Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure. , 2005, The American journal of cardiology.

[10]  F. Pigula,et al.  Interim mortality in infants with systemic-to-pulmonary artery shunts. , 2003, The Annals of thoracic surgery.

[11]  P. D. del Nido,et al.  Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. , 2003, The Journal of thoracic and cardiovascular surgery.

[12]  P. D. del Nido,et al.  Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. , 2002, The Annals of thoracic surgery.

[13]  R. Junker,et al.  Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study. , 2001, Thrombosis research.

[14]  J. Rychik,et al.  Thrombus formation after the Fontan operation. , 2001, The Annals of thoracic surgery.

[15]  V. Hjortdal,et al.  Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection , 2001, Heart.

[16]  E. Bacha,et al.  Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. , 2000, The Journal of thoracic and cardiovascular surgery.

[17]  A. Ahlbom,et al.  Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[18]  J. Tijssen,et al.  Abnormalities in liver function and coagulation profile following the Fontan procedure , 1999, Heart.

[19]  K. Huber,et al.  Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[20]  P. Monagle,et al.  Coagulation abnormalities after Fontan procedures. , 1998, The Journal of thoracic and cardiovascular surgery.

[21]  B. McCrindle,et al.  Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation. , 1998, The Journal of thoracic and cardiovascular surgery.

[22]  W. Chandler,et al.  Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. , 1997, Circulation.

[23]  E. Shinebourne,et al.  Coagulation factor abnormalities after the Fontan procedure and its modifications. , 1997, The Journal of thoracic and cardiovascular surgery.

[24]  J. Griffin,et al.  Central venous thrombosis after cardiac operations in children. , 1996, The Journal of thoracic and cardiovascular surgery.

[25]  D. Rosenthal,et al.  Thromboembolic complications after Fontan operations. , 1995, Circulation.

[26]  J. Morrow,et al.  Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry. , 1993, Journal of chromatography.

[27]  H. Hillege,et al.  Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations , 1990, The Lancet.